ketoconazole has been researched along with Pleural Diseases in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Pleural Diseases: Diseases involving the PLEURA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Failla, PJ | 1 |
Cerise, FP | 1 |
Karam, GH | 1 |
Summer, WR | 1 |
1 other study available for ketoconazole and Pleural Diseases
Article | Year |
---|---|
Blastomycosis: pulmonary and pleural manifestations.
Topics: Adult; Amphotericin B; Blastomycosis; Child; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Ma | 1995 |